UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

Polymorphisms in the TP53-MDM2-MDM4-axis in patients with rheumatoid arthritis

Gene, 2021-08, Vol.793, p.145747-145747, Article 145747

2021

Volltextzugriff (PDF)

SNP285C modulates oestrogen receptor/Sp1 binding to the MDM2 promoter and reduces the risk of endometrial but not prostatic cancer

European journal of cancer (1990), 2012-09, Vol.48 (13), p.1988-1996

2012

Volltextzugriff (PDF)

Breast cancer aromatase expression evaluated by the novel antibody 677: Correlations to intra-tumor estrogen levels and hormone receptor status

Journal of steroid biochemistry and molecular biology, 2010-02, Vol.118 (4), p.237-241

2010

Volltextzugriff (PDF)

Impact of aromatase inhibitors on bone health in breast cancer patients

Journal of steroid biochemistry and molecular biology, 2010-02, Vol.118 (4), p.294-299

2010

Volltextzugriff (PDF)

Functional characterisation of p53 mutants identified in breast cancers with suboptimal responses to anthracyclines or mitomycin

Biochimica et biophysica acta, 2013-03, Vol.1830 (3), p.2790-2797

2013

Volltextzugriff (PDF)

Recent data on intratumor estrogens in breast cancer

Steroids, 2011-07, Vol.76 (8), p.786-791

2011

Volltextzugriff (PDF)

Aromatase inhibitors: Assessment of biochemical efficacy measured by total body aromatase inhibition and tissue estrogen suppression

Journal of steroid biochemistry and molecular biology, 2008-02, Vol.108 (3), p.196-202

2008

Volltextzugriff (PDF)

Aromatase inhibitors—Socioeconomical issues

Journal of steroid biochemistry and molecular biology, 2007-08, Vol.106 (1), p.55-61

2007

Volltextzugriff (PDF)

The IGF-system in healthy pre- and postmenopausal women: relations to demographic variables and sex-steroids

The Journal of steroid biochemistry and molecular biology, 2002-05, Vol.81 (1), p.95-102

2002

Volltextzugriff (PDF)

Aromatase inhibitors as adjuvant treatment of breast cancer

Critical reviews in oncology/hematology, 2006, Vol.57 (1), p.53-61

2006

Volltextzugriff (PDF)

Aromatase inhibitors—Socio-economical issues

Journal of steroid biochemistry and molecular biology, 2005-05, Vol.95 (1), p.137-142

2005

Volltextzugriff (PDF)

Alterations in the insulin-like growth factor system during the menstrual cycle in normal women

Maturitas, 1998-01, Vol.28 (3), p.259-265

1998

Volltextzugriff (PDF)

Mechanisms of action of endocrine treatment in breast cancer

Critical reviews in oncology/hematology, 1995-11, Vol.21 (1), p.158-193

1995

Volltextzugriff (PDF)

X chromosome inactivation in cervical cancer patients

Cancer genetics and cytogenetics, 2003-10, Vol.146 (1), p.73-76

2003

Volltextzugriff (PDF)

Influence of treatment with onapristone on the IGF-system in breast cancer patients

The Journal of steroid biochemistry and molecular biology, 1998-08, Vol.66 (3), p.159-163

1998

Volltextzugriff (PDF)

Influence of droloxifene on plasma levels of insulin-like growth factor (IGF)-I, pro-IGF-IIE, insulin-like growth factor binding protein (IGFBP)-1 and IGFBP-3 in breast cancer patients

The Journal of steroid biochemistry and molecular biology, 1996-02, Vol.57 (3), p.167-171

1996

Volltextzugriff (PDF)

Use of endocrine therapy to study the biology of breast cancer

Cancer treatment reviews, 1993-04, Vol.19, p.65-77

Lønning, Per E.

1993

Volltextzugriff (PDF)

Genes causing inherited cancer as beacons to identify the mechanisms of chemoresistance

Trends in molecular medicine, 2004-03, Vol.10 (3), p.113-118

Lønning, Per Eystein

2004

Volltextzugriff (PDF)

A novel HPLC-RIA method for the simultaneous detection of estrone, estradiol and estrone sulphate levels in breast cancer tissue

The Journal of steroid biochemistry and molecular biology, 2000-04, Vol.72 (5), p.259-264

2000

Volltextzugriff (PDF)

Endocrine effects of aromatase inhibitors and inactivators in vivo: Review of data and method limitations

Journal of steroid biochemistry and molecular biology, 2005-05, Vol.95 (1), p.75-81

2005

Volltextzugriff (PDF)

Stepwise estrogen suppression manipulating the estrostat

Journal of steroid biochemistry and molecular biology, 2001-12, Vol.79 (1), p.127-132

Lønning, Per Eystein

2001

Volltextzugriff (PDF)

PML-nuclear bodies accumulate DNA in response to polyomavirus BK and simian virus 40 replication

Experimental cell research, 2004-08, Vol.298 (1), p.58-73

2004

Volltextzugriff (PDF)

Comparison between aromatase inhibitors and sequential use

Journal of steroid biochemistry and molecular biology, 2003-09, Vol.86 (3), p.275-282

Lønning, Per Eystein

2003

Volltextzugriff (PDF)

Role of endocrine therapy in breast cancer—where are we going?

Baillière's best practice & research. Clinical endocrinology & metabolism, 2004-03, Vol.18 (1), p.vii-ix

Lønning, Per Eystein

2004

Volltextzugriff (PDF)

Oestrogen suppression—lessons from clinical studies

Baillière's best practice & research. Clinical endocrinology & metabolism, 2004-03, Vol.18 (1), p.33-45

Lønning, Per Eystein

2004

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)
Japanisch
(2)

Erscheinungsjahr

n.n

Kollektion

Elsevier ScienceDirect Journals Complete
(31)
Ingenta
(30)
MEDLINE
(29)
IngentaConnect Journals
(7)
Journals@Ovid Complete
(2)

Menü

Weitere Dienste

Einstellungen

Polymorphisms in the TP53-MDM2-MDM4-axis in patients with rheumatoid arthritis

SNP285C modulates oestrogen receptor/Sp1 binding to the MDM2 promoter and reduces the risk of endometrial but not prostatic cancer

Breast cancer aromatase expression evaluated by the novel antibody 677: Correlations to intra-tumor estrogen levels and hormone receptor status

Impact of aromatase inhibitors on bone health in breast cancer patients

Functional characterisation of p53 mutants identified in breast cancers with suboptimal responses to anthracyclines or mitomycin

Recent data on intratumor estrogens in breast cancer

Aromatase inhibitors: Assessment of biochemical efficacy measured by total body aromatase inhibition and tissue estrogen suppression

Aromatase inhibitors—Socioeconomical issues

The IGF-system in healthy pre- and postmenopausal women: relations to demographic variables and sex-steroids

Aromatase inhibitors as adjuvant treatment of breast cancer

Aromatase inhibitors—Socio-economical issues

Alterations in the insulin-like growth factor system during the menstrual cycle in normal women

Mechanisms of action of endocrine treatment in breast cancer

X chromosome inactivation in cervical cancer patients

Influence of treatment with onapristone on the IGF-system in breast cancer patients

Influence of droloxifene on plasma levels of insulin-like growth factor (IGF)-I, pro-IGF-IIE, insulin-like growth factor binding protein (IGFBP)-1 and IGFBP-3 in breast cancer patients

Use of endocrine therapy to study the biology of breast cancer

Genes causing inherited cancer as beacons to identify the mechanisms of chemoresistance

A novel HPLC-RIA method for the simultaneous detection of estrone, estradiol and estrone sulphate levels in breast cancer tissue

Endocrine effects of aromatase inhibitors and inactivators in vivo: Review of data and method limitations

Stepwise estrogen suppression manipulating the estrostat

PML-nuclear bodies accumulate DNA in response to polyomavirus BK and simian virus 40 replication

Comparison between aromatase inhibitors and sequential use

Role of endocrine therapy in breast cancer—where are we going?

Oestrogen suppression—lessons from clinical studies

Aktive Filter

Suchergebnisse filtern